“Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years—United States, June 2022” published in MMWR
CDC published Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years—United States, June 2022 in the July 1 issue of MMWR. A portion of the summary appears below.
On June 17, 2022, the Food and Drug Administration granted Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines for children aged 6 months–5 years and 6 months–4 years, respectively....
On June 18, 2022, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the use of the Moderna COVID-19 vaccine for children aged 6 months–5 years and for the Pfizer-BioNTech COVID-19 vaccine for children aged 6 months–4 years in the United States for prevention of COVID-19. ACIP determined that the benefits of vaccination outweigh risks for this population....
Vaccination is important for protecting children aged 6 months–5 years against COVID-19.
Access the MMWR article in HTML or PDF.
CDC offers resources for healthcare professionals on the ongoing monkeypox outbreak, including vaccine guidance and how to identify monkeypox
CDC is closely tracking cases of monkeypox detected in the United States during the 2022 monkeypox outbreak. Early data suggest that gay, bisexual, and other men who have sex with men make up a high number of cases. However, anyone who has been in close contact with someone who has monkeypox is at risk.
CDC urges healthcare providers in the United States to be alert for patients with a rash consistent with monkeypox regardless of their specific risk factors for monkeypox. Use the following CDC resources to familiarize yourself with this disease and how it appears.
At this time, CDC does not recommend widespread vaccination against monkeypox. However, vaccination may be recommended for some people who:
- Are in close personal contact with people who have monkeypox
- May have been exposed to the virus
- May have an increased risk of being exposed to the virus, such as people who perform laboratory testing to diagnose monkeypox
Immunize.org posts Spanish translation of smallpox/monkeypox Vaccine Information Statement
Immunize.org posted a new Spanish-language translation of CDC’s Vaccine Information Statement (VIS) for smallpox/monkeypox. The translation was generously donated by Multilingual Services, CDC.
Back to top
Immunize.org posts new Vaccine Information Statement for Ebola vaccine
Immunize.org posted the Ebola Vaccine Information Statement (VIS) that CDC released on June 30.
View the Ebola VIS.
Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)"
Immunize.org updated two key documents to include the new Ebola Vaccine Information Statement.
Back to top
Immunize.org updates two patient handouts, "Vaccinations Needed during Pregnancy" and "Human Papillomavirus (HPV): A Parent's Guide to Preteen and Teen HPV Vaccination"
Immunize.org recently updated two patient handouts, one for pregnancy and one for parents of preteens/teens.
Back to top
Immunize.org revises “Standing Orders for Administering Inactivated Poliovirus Vaccine to Children and Teens”
Immunize.org updated its Standing Orders for Administering Inactivated Poliovirus Vaccine to Children and Teens document. Edits were made to highlight the following:
“If a child received 4 or more doses before their 4th birthday (e.g., in a combination vaccine), an additional dose is still necessary after the 4th birthday and at least 6 months after the previous dose. This excludes people whose 4th dose was administered prior to August 6, 2009.”
Invite your colleagues to subscribe to IZ Express
so they don’t miss out on immunization news!
IZ Express, the free weekly e-newsletter produced by Immunize.org, succinctly summarizes each week’s important vaccine developments, including new and updated recommendations from CDC and the latest vaccine decisions by FDA. IZ Express also features:
- Newly posted Vaccine Information Statements and their translations
- Educational materials from Immunize.org, CDC, AAP, and others
- Notices about online and in-person educational opportunities, many offering free continuing education credit
We appreciate you as a subscriber! Encourage your co-workers to subscribe to IZ Express themselves so they get everything that matters to vaccinators in their own inbox each Wednesday.
Spotlight: Check out Immunize.org’s companion websites
Immunize.org sponsors several companion websites that can help you.
Information about the National Network of Immunization Coalitions, a project of Immunize.org, can be found at www.immunizationcoalitions.org. This website compiles information on more than 100 immunization coalitions and their topics of shared interest.
The National Adult and Influenza Immunization Summit (NAIIS) website at www.izsummitpartners.org addresses adult and influenza immunization issues to improve coverage. The NAIIS has more than 700 members, representing more than 130 public and private organizations. The NAIIS is led by members of the Summit Organizing Committee, including Immunize.org, CDC, and other federal representatives.
Vaccine Information You Need at www.vaccineinformation.org was launched by Immunize.org in partnership with CDC to help inform the public. This website provides hundreds of valuable resources, including personal testimonies of suffering due to vaccine-preventable diseases, vaccine-related videos and public-service announcements, and educational materials from trusted organizations.
MenACWY: You’re Not Done If You Give Just One at www.give2menacwy.org supports a national campaign produced by Immunize.org and Sanofi Pasteur to improve protection from disease caused by meningococcal serogroups A, C, W, and Y. It offers information for families and resources for providers to boost on-time delivery of both doses of the MenACWY vaccine.
65+ Flu Defense at www.influenza-defense.org is a public health service produced by Immunize.org and Seqirus. The website offers tools and resources to help protect patients 65 and older, all of whom are at greater risk of influenza complications.
Journalists interview Immunize.org experts
Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is one of our recent citations.
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Back to top
Immunize.org Pages and Handouts
Recap: These updated Immunize.org educational materials and web pages for clinicians were released during May and June
IZ Express regularly provides readers with information about Immunize.org’s new and updated educational materials and web pages. All Immunize.org materials are free to distribute.
Immunize.org Updated Web Pages
Immunize.org Updated PDF Materials for Patients
In case you missed them during recent weeks, updates were made to these helpful materials:
Immunize.org Updated PDF Materials for Clinicians
- Immunize.org: Handouts main page to see educational materials sorted by category
- Immunize.org: Ask the Experts main page to access more than 1,100 questions answered by Immunize.org experts
- Immunize.org: Clinic Tools main page and its nine subtopics
- Immunize.org: Educational Materials for Patients and Staff—an alphabetical list of more than 230 ready-to-print staff educational materials and patient handouts
Vaccine Information Statements
Recap: These new VISs and VIS translations were released during May and June
IZ Express regularly provides readers with information about new and updated Vaccine Information Statements (VISs) and their translations.
Six new Ukrainian VIS translations were added:
In June, CDC released two VISs, an updated Rabies VIS and a new Smallpox/Monkeypox VIS.
Additionally, two handouts related to VISs were updated:
CDC offers “You Call the Shots” interactive, web-based training that discusses vaccine-preventable diseases and vaccination, including updated pneumococcal and meningococcal modules; CME, CNE, and CPE available
CDC is offering a free, interactive, web-based immunization training course, You Call the Shots, which consists of modules that discuss vaccine-preventable diseases and explain the latest recommendations for vaccine use. Each module provides learning opportunities, self-test practice questions, reference and resource materials, and an extensive glossary. The course is updated regularly to include the latest guidelines and recommendations in vaccine practice.
CME, CNE, CPE, and CEU are available upon completion of the training course.
The pneumococcal module and meningococcal module were both updated in June.
View all of the training modules on CDC's You Call the Shots web page.
Back to top
Vaccinate Your Family launches “Their Best Shot” campaign to raise awareness of missed childhood vaccinations during the COVID-19 pandemic
Vaccinate Your Family (VYF) launched Their Best Shot, a community campaign to raise awareness of childhood vaccinations missed during the COVID-19 pandemic. The campaign offers parents an overview on how they can get their children up to date on their vaccines during the summer.
VYF also offers a partner toolkit with graphics, talking points, and FAQs on the COVID-19 recommendation for children younger than age 5 years. Available in English and Spanish, these materials are free for you to co-brand, repurpose, and use to advocate for COVID-19 protection.
Sesame Street releases “Elmo Gets the COVID-19 Vaccine” PSA, noting that vaccination is the best way to stay healthy
Sesame Street released a public service announcement (PSA) titled Elmo Gets the COVID-19 Vaccine noting that vaccination is the best way to keep yourself and everyone around you healthy. Watch the video together with children and ask if they have any questions about the COVID-19 vaccine. Talk about some things that might make getting a shot a little easier, such as hugging a special toy, or picking out a special bandage like Elmo’s.
Immunize.org congratulates Elmo, Louie (his father), Big Bird, and everyone in the Sesame Street community for their ongoing commitment to disease prevention. We encourage them to sign up for v-safe too!
NFID releases two infographics on pneumococcal disease and the vaccines for adults, as well as “Protecting Adults from Pneumococcal Disease through Vaccination” training module; CE available
National Foundation for Infectious Diseases (NFID) released two new infographics on pneumococcal disease and vaccination for adults.
NFID also released a training module, Protecting Adults from Pneumococcal Disease through Vaccination, based on the latest CDC recommendations. It includes practical strategies to implement pneumococcal vaccination. CE is available upon completion.
Visit the training module.
“COVID-19 Vaccine Provider Availability and Vaccination Coverage among Children Aged 5–11 Years—United States, November 1, 2021–April 25, 2022” published in MMWR
CDC published COVID-19 Vaccine Provider Availability and Vaccination Coverage among Children Aged 5–11 Years—United States, November 1, 2021–April 25, 2022 in the July 1 MMWR. An excerpt follows.
Among the five assessed active provider types, most counties had at least one pharmacy (69.1%) or public health clinic (61.3%), whereas fewer counties had at least one pediatric clinic (29.7%), family medicine clinic (29.0%), or federally qualified health center (FQHC)* (22.8%). Median county-level vaccination coverage was 14.5%.
By April 25, 2022, most U.S. counties had a pharmacy or public health clinic offering COVID-19 vaccines to children aged 5–11 years; fewer counties had a pediatric clinic, family medicine clinic, or federally qualified health center. The availability of each provider type was associated with higher county-level vaccination coverage among children aged 5–11 years… Ensuring broad access to COVID-19 vaccines, in addition to other strategies to address vaccination barriers, could help increase vaccination coverage among children aged 5–11.
Access the MMWR article in HTML or PDF.